Davide Edghill

Evan Greger joined Pionyr Immunotherapeutics in June 2018 and has over 20 years of experience in leadership roles in biopharmaceutical companies, with research, process/product development, manufacturing, CMC, and regulatory expertise. Prior to Pionyr, he served as VP, CMC and Process Development for Cell Design Labs / Kite Pharma, where he worked on next-generation CAR T therapy, and was the Senior Director, Manufacturing Process Sciences at Juno Therapeutics, where he advanced CAR T therapies into the EU with Celgene and into China with JW Therapeutics. Prior to this role, Mr. Greger was the Global Head of Manufacturing Sciences and Technology for Biopharmaceutical Operations with Novartis in Basel, Switzerland. He previously held senior positions with Amgen, where he led Enbrel commercialization, and advanced the oncology and biosimilar pipeline, and at Sanofi Pasteur and Alpharma, where he advanced vaccine development and commercialization. Mr. Greger holds an MBA from Seattle University and an MSc from the University of Washington.